Literature DB >> 30593588

c-Myc promotes tubular cell apoptosis in ischemia-reperfusion-induced renal injury by negatively regulating c-FLIP and enhancing FasL/Fas-mediated apoptosis pathway.

Dan Xu1, Bao Wang1, Pan-Pan Chen1, Yan-Zhe Wang2, Nai-Jun Miao1, Fan Yin1, Qian Cheng1, Zhuan-Li Zhou1, Hong-Yan Xie1, Li Zhou1, Jun Liu1, Xiao-Xia Wang2, Hong Xue3, Wei Zhang4, Li-Min Lu5.   

Abstract

c-Myc plays an important role in cell proliferation, differentiation, and cell apoptosis. FasL/Fas pathway is a key regulator of cell apoptosis. This study was aimed to investigate the effects of c-Myc on the FasL/Fas pathway in ischemia-reperfusion (I/R)-induced renal injury. Rats were objected to bilateral renal ischemia for 60 min and reperfused for 24 or 48 h. NRK-52E cells were treated with hypoxia-reoxygenation (H/R) or FasL. Immunohistochemistry was used to identify the distribution of c-Myc. Cell apoptosis was assessed by TUNEL staining. Ad-c-Myc and recombinant pcDAN 3.0 were used to overexpress c-Myc and c-FLIP, respectively. ChIP assay and luciferase assay were used to detect the binding of c-Myc to c-FLIP promoter. In I/R rats, c-Myc was increased significantly and mainly located in renal tubular epithelial cells; meanwhile, c-FLIP was decreased, cleaved caspase-8, cleaved caspase-3 and TUNEL-positive staining cells were increased. Treatment of I/R rats with c-Myc inhibitor 10058-F4 significantly attenuated the decrease in c-FLIP, the increase in cleaved caspase-8, cleaved caspase-3, TUNEL-positive cells, Scr and BUN in I/R rats. In NRK-52E cells, hypoxia and reoxygen induced the increase in c-Myc and decrease in c-FLIP. ChIP and luciferase assay results indicated that c-Myc binds to the promoter region of c-FLIP gene. Overexpression of c-Myc markedly decreased c-FLIP. Overexpression of c-FLIP inhibited the increase in cleaved caspase-8 and caspase-3 induced by FasL. Data indicated that c-Myc is increased in kidneys of I/R rats and negatively regulates the expression of c-FLIP, then enhanced FasL-induced cell apoptosis in I/R stress.

Entities:  

Keywords:  FasL/Fas; c-FLIP; c-Myc; ischemia-reperfusion; tubular cell apoptosis

Mesh:

Substances:

Year:  2018        PMID: 30593588      PMCID: PMC6786400          DOI: 10.1038/s41401-018-0201-9

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  4 in total

1.  Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas.

Authors:  S Nogae; M Miyazaki; N Kobayashi; T Saito; K Abe; H Saito; P K Nakane; Y Nakanishi; T Koji
Journal:  J Am Soc Nephrol       Date:  1998-04       Impact factor: 10.121

2.  Effect of puerarin on expression of Fas/FasL mRNA in pulmonary injury induced by ischemia-reperfusion in rabbits.

Authors:  Mengxiao Zheng; Dong Song; Ziyin Luo; Zhongqiu Lu; Yiming Wu; Wantie Wang
Journal:  Nat Prod Commun       Date:  2015-02       Impact factor: 0.986

3.  Fas/FasL induces myocardial cell apoptosis in myocardial ischemia-reperfusion rat model.

Authors:  X-M Liu; Z-M Yang; X-K Liu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-06       Impact factor: 3.507

Review 4.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10
  4 in total
  8 in total

Review 1.  Impact of native and external factors on exosome release: understanding reactive exosome secretion and its biogenesis.

Authors:  Harini Hariharan; Yasodha Kesavan; Natesan Sella Raja
Journal:  Mol Biol Rep       Date:  2021-10-09       Impact factor: 2.316

Review 2.  Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies - exemplified by polyunsaturated fatty acids and other ROS-modulating agents.

Authors:  Rui Xue Zhang; Franky Fuh-Ching Liu; Hoyin Lip; Junhong Liu; Qianrong Zhang; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2022-01-22       Impact factor: 5.671

Review 3.  Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease.

Authors:  Mingming Zhao; Yi Yu; Rumeng Wang; Meiying Chang; Sijia Ma; Hua Qu; Yu Zhang
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

4.  Induction of ligustrazine apoptosis of A549 cells through activation of death receptor pathway.

Authors:  Wei Zheng; Jihua Yang; Juyi Wen; Junzhao Sun; Jing Wang; Xinhong Zhang; Xia Zhang; Xiangfei Zhao; Henghu Fang; Qi Zhu; Shanshan Wu; Zejun Lu; Heng Sun; Rugang Zhao; Siyuan Huai; Lipin Gao; Yongzhen Liu; Jingjiao Li; Gaowa Guan; Wei Yang; Yi Hu
Journal:  Transl Cancer Res       Date:  2022-03       Impact factor: 1.241

Review 5.  Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products.

Authors:  Wei Tan; Yunyan Wang; Hongmei Dai; Junhui Deng; Zhifen Wu; Lirong Lin; Jurong Yang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

6.  KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury.

Authors:  Dan Xu; Pan-Pan Chen; Pei-Qing Zheng; Fan Yin; Qian Cheng; Zhuan-Li Zhou; Hong-Yan Xie; Jing-Yao Li; Jia-Yun Ni; Yan-Zhe Wang; Si-Jia Chen; Li Zhou; Xiao-Xia Wang; Jun Liu; Wei Zhang; Li-Min Lu
Journal:  Acta Pharmacol Sin       Date:  2020-07-09       Impact factor: 6.150

7.  Effects of cyclosporin A pre-treatment combined with etomidate post-treatment on lung injury induced by limb ischemia-reperfusion in rats.

Authors:  Haibo Zou; Xiaofeng Sun
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

8.  Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury.

Authors:  Louisa M S Gerhardt; Jing Liu; Kari Koppitch; Pietro E Cippà; Andrew P McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.